These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 21049090)
41. A phase 1, randomized, open-label, single-dose study to assess the relative bioavailability of a subcutaneous dose of FKB327 when administered using a prefilled syringe, a prefilled auto-injector, or a vial with disposable syringe in healthy subjects. Bush J; Kawakami K; Muniz R BMC Pharmacol Toxicol; 2019 Dec; 20(1):87. PubMed ID: 31888742 [TBL] [Abstract][Full Text] [Related]
42. A novel electromechanical autoinjector, AutoTouch™, for self-injection of etanercept: real-world use and benefits. Collier DH; Bitman B; Coles A; Liu L; Kumar S; Judd C Postgrad Med; 2017 Jan; 129(1):118-125. PubMed ID: 27829325 [TBL] [Abstract][Full Text] [Related]
43. Subcutaneous Injection Performance in Yucatan Miniature Pigs with and without Human Hyaluronidase and Auto-injector Tolerability in Humans. Shi GH; Connor RJ; Collins DS; Kang DW AAPS PharmSciTech; 2021 Jan; 22(1):39. PubMed ID: 33409604 [TBL] [Abstract][Full Text] [Related]
44. Usability and safety of SB5 (an adalimumab biosimilar) prefilled syringe and autoinjector in patients with rheumatoid arthritis. Ghil J; Zielińska A; Lee Y Curr Med Res Opin; 2019 Mar; 35(3):497-502. PubMed ID: 30561229 [TBL] [Abstract][Full Text] [Related]
45. Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus . Sheikh SZ; Hammer AE; Fox NL; Groark J; Struemper H; Roth D; Gordon D Int J Clin Pharmacol Ther; 2016 Nov; 54(11):914-922. PubMed ID: 27668697 [TBL] [Abstract][Full Text] [Related]
46. The role of training in effective simulated self-injection of subcutaneous depot medroxyprogesterone acetate: observations from a usability study. Kaplan I; Ross D; Hilton F; Morgenstern D; Wolter K Contraception; 2016 Oct; 94(4):314-20. PubMed ID: 27241898 [TBL] [Abstract][Full Text] [Related]
47. Results from the single-use autoinjector for self-administration of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis (MOSAIC) study. Wray S; Armstrong R; Herrman C; Calkwood J; Cascione M; Watsky E; Hayward B; Mercer B; Dangond F Expert Opin Drug Deliv; 2011 Dec; 8(12):1543-53. PubMed ID: 22032264 [TBL] [Abstract][Full Text] [Related]
48. Enabling faster subcutaneous delivery of larger volume, high viscosity fluids. Rini CJ; Roberts BC; Vaidyanathan A; Li A; Klug R; Sherman DB; Pettis RJ Expert Opin Drug Deliv; 2022 Sep; 19(9):1165-1176. PubMed ID: 36053114 [TBL] [Abstract][Full Text] [Related]
49. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate. Pichlmeier U; Heuer KU Clin Exp Rheumatol; 2014; 32(4):563-71. PubMed ID: 24983446 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance. Berteau C; Filipe-Santos O; Wang T; Rojas HE; Granger C; Schwarzenbach F Med Devices (Auckl); 2015; 8():473-84. PubMed ID: 26635489 [TBL] [Abstract][Full Text] [Related]
51. Computational modeling of the effect of skin pinch and stretch on subcutaneous injection of monoclonal antibodies using autoinjector devices. de Lucio M; Leng Y; Wang H; Ardekani AM; Vlachos PP; Shi G; Gomez H Biomech Model Mechanobiol; 2023 Dec; 22(6):1965-1982. PubMed ID: 37526775 [TBL] [Abstract][Full Text] [Related]
52. Subcutaneous administration of midazolam: a comparison of the Bioject jet injector with the conventional syringe and needle. Bennett J; Nichols F; Rosenblum M; Condry J J Oral Maxillofac Surg; 1998 Nov; 56(11):1249-54. PubMed ID: 9820211 [TBL] [Abstract][Full Text] [Related]
53. Clinical evaluation of large volume subcutaneous injection tissue effects, pain, and acceptability in healthy adults. Woodley WD; Morel DR; Sutter DE; Pettis RJ; Bolick NG Clin Transl Sci; 2022 Jan; 15(1):92-104. PubMed ID: 34268888 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of an investigational wearable injector in healthy human volunteers. Torjman MC; Machnicki R; Lessin J; Loeum C; Steinberger D; Mycroft S; Joseph JI Expert Opin Drug Deliv; 2017 Jan; 14(1):7-13. PubMed ID: 27809609 [TBL] [Abstract][Full Text] [Related]
55. Subcutaneous sumatriptan delivery devices: comparative ease of use and preference among migraineurs. Andre AD; Brand-Schieber E; Ramirez M; Munjal S; Kumar R Patient Prefer Adherence; 2017; 11():121-129. PubMed ID: 28176899 [TBL] [Abstract][Full Text] [Related]
56. Nurse and Patient Perceptions and Preferences for Subcutaneous Autoinjectors for Inflammatory Joint or Bowel Disease: Findings from a European Survey. Fenwick S; Thakur K; Munro D Rheumatol Ther; 2019 Jun; 6(2):195-206. PubMed ID: 30790242 [TBL] [Abstract][Full Text] [Related]
57. Immunogenicity and safety of measles-mumps-rubella vaccine delivered by disposable-syringe jet injector in healthy Brazilian infants: a randomized non-inferiority study. de Menezes Martins R; Curran B; Maia Mde L; Ribeiro Md; Camacho LA; da Silva Freire M; Yamamura AM; Siqueira MM; Lemos MC; de Albuquerque EM; von Doellinger Vdos R; Homma A; Saganic L; Jarrahian C; Royals M; Zehrung D Contemp Clin Trials; 2015 Mar; 41():1-8. PubMed ID: 25476584 [TBL] [Abstract][Full Text] [Related]
58. Patient Satisfaction with the New Interferon Beta-1b Autoinjector (BETACONNECT™). Ziemssen T; Sylvester L; Rametta M; Ross AP Neurol Ther; 2015 Dec; 4(2):125-36. PubMed ID: 26662362 [TBL] [Abstract][Full Text] [Related]
59. Imaging of large volume subcutaneous deposition using MRI: exploratory clinical study results. Pettis RJ; Woodley WD; Ossege KC; Blum A; Bolick NG; Rini CJ Drug Deliv Transl Res; 2023 Sep; 13(9):2353-2366. PubMed ID: 36913105 [TBL] [Abstract][Full Text] [Related]
60. Mode of injection and treatment adherence: results of a survey characterizing the perspectives of health care providers and US women 18-45 years old. Gandell DL; Bienen EJ; Gudeman J Patient Prefer Adherence; 2019; 13():351-361. PubMed ID: 30863023 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]